Is Zimmer Biomet Stock a Good Investment?
Zimmer Biomet Investment Advice | ZBH |
- Examine Zimmer Biomet's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Zimmer Biomet's leadership team and their track record. Good management can help Zimmer Biomet navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Zimmer Biomet's business and its evolving consumer preferences.
- Compare Zimmer Biomet's performance and market position to its competitors. Analyze how Zimmer Biomet is positioned in terms of product offerings, innovation, and market share.
- Check if Zimmer Biomet pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Zimmer Biomet's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Zimmer Biomet Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Zimmer Biomet Holdings is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Zimmer Biomet Stock
Researching Zimmer Biomet's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 94.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.76. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zimmer Biomet Holdings has Price/Earnings To Growth (PEG) ratio of 1.51. The entity last dividend was issued on the 31st of March 2025. The firm had 103:100 split on the 1st of March 2022.
To determine if Zimmer Biomet is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Zimmer Biomet's research are outlined below:
| Over 94.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: 771,063 Shares in Zimmer Biomet Holdings, Inc. Bought by Sound Shore Management Inc. CT |
Zimmer Biomet Quarterly Liabilities And Stockholders Equity |
|
Zimmer Biomet uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Zimmer Biomet Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Zimmer Biomet's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Zimmer Biomet's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Zimmer Biomet's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2002-10-21 | 2002-09-30 | 0.3 | 0.33 | 0.03 | 10 | ||
2002-04-24 | 2002-03-31 | 0.25 | 0.28 | 0.03 | 12 | ||
2002-07-24 | 2002-06-30 | 0.3 | 0.34 | 0.04 | 13 | ||
2005-01-31 | 2004-12-31 | 0.64 | 0.71 | 0.07 | 10 | ||
2005-04-25 | 2005-03-31 | 0.67 | 0.75 | 0.08 | 11 | ||
2008-01-29 | 2007-12-31 | 1.04 | 1.18 | 0.14 | 13 | ||
2022-08-02 | 2022-06-30 | 1.65 | 1.82 | 0.17 | 10 | ||
2021-05-04 | 2021-03-31 | 1.53 | 1.71 | 0.18 | 11 |
Zimmer Biomet Target Price Consensus
Zimmer target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Zimmer Biomet's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 30 | Buy |
Most Zimmer analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Zimmer stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Zimmer Biomet Holdings, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationZimmer Biomet Target Price Projection
Zimmer Biomet's current and average target prices are 110.38 and 124.50, respectively. The current price of Zimmer Biomet is the price at which Zimmer Biomet Holdings is currently trading. On the other hand, Zimmer Biomet's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Zimmer Biomet Market Quote on 26th of March 2025
Target Price
Analyst Consensus On Zimmer Biomet Target Price
Zimmer Biomet Analyst Ratings
Zimmer Biomet's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Zimmer Biomet stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Zimmer Biomet's financials, market performance, and future outlook by experienced professionals. Zimmer Biomet's historical ratings below, therefore, can serve as a valuable tool for investors.Know Zimmer Biomet's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Zimmer Biomet is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zimmer Biomet Holdings backward and forwards among themselves. Zimmer Biomet's institutional investor refers to the entity that pools money to purchase Zimmer Biomet's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Allspring Global Investments Holdings, Llc | 2024-12-31 | 2.6 M | Citadel Advisors Llc | 2024-12-31 | 2.4 M | Northern Trust Corp | 2024-12-31 | 2.4 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 2.2 M | Norges Bank | 2024-12-31 | 2 M | Dimensional Fund Advisors, Inc. | 2024-12-31 | 2 M | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 1.8 M | Hotchkis & Wiley Capital Management Llc | 2024-12-31 | 1.7 M | Boston Partners Global Investors, Inc | 2024-12-31 | 1.6 M | Vanguard Group Inc | 2024-12-31 | 22.9 M | Dodge & Cox | 2024-12-31 | 19.1 M |
Zimmer Biomet's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 22.14 B.Market Cap |
|
Zimmer Biomet's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.12 | 0.17 | |
| Return On Capital Employed | 0.07 | 0.06 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.07 | 0.07 |
Determining Zimmer Biomet's profitability involves analyzing its financial statements and using various financial metrics to determine if Zimmer Biomet is a good buy. For example, gross profit margin measures Zimmer Biomet's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Zimmer Biomet's profitability and make more informed investment decisions.
Zimmer Biomet's Earnings Breakdown by Geography
Evaluate Zimmer Biomet's management efficiency
Zimmer Biomet Holdings has Return on Asset of 0.0465 % which means that on every $100 spent on assets, it made $0.0465 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0725 %, implying that it generated $0.0725 on every 100 dollars invested. Zimmer Biomet's management efficiency ratios could be used to measure how well Zimmer Biomet manages its routine affairs as well as how well it operates its assets and liabilities. The Zimmer Biomet's current Return On Tangible Assets is estimated to increase to 0.17, while Return On Capital Employed is projected to decrease to 0.06. As of now, Zimmer Biomet's Asset Turnover is decreasing as compared to previous years.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 61.43 | 64.50 | |
| Tangible Book Value Per Share | (5.28) | (5.55) | |
| Enterprise Value Over EBITDA | 12.05 | 17.34 | |
| Price Book Value Ratio | 1.72 | 1.63 | |
| Enterprise Value Multiple | 12.05 | 17.34 | |
| Price Fair Value | 1.72 | 1.63 | |
| Enterprise Value | 14.4 B | 12.8 B |
Zimmer Biomet's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Basic technical analysis of Zimmer Stock
As of the 26th of March, Zimmer Biomet maintains the Market Risk Adjusted Performance of 0.1948, downside deviation of 1.58, and Mean Deviation of 1.13. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zimmer Biomet Holdings, as well as the relationship between them.Zimmer Biomet's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zimmer Biomet insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zimmer Biomet's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zimmer Biomet insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zimmer Biomet's Outstanding Corporate Bonds
Zimmer Biomet issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zimmer Biomet Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zimmer bonds can be classified according to their maturity, which is the date when Zimmer Biomet Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| ZIMMER BIOMET HLDGS Corp BondUS98956PAG72 | View | |
| ZIMMER BIOMET HLDGS Corp BondUS98956PAF99 | View | |
| US98956PAB85 Corp BondUS98956PAB85 | View | |
| ZIMMER BIOMET HLDGS Corp BondUS98956PAH55 | View | |
| ZBH 26 24 NOV 31 Corp BondUS98956PAV40 | View | |
| ZIMMER BIOMET HOLDINGS Corp BondUS98956PAT93 | View | |
| US98956PAS11 Corp BondUS98956PAS11 | View |
Understand Zimmer Biomet's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Zimmer Biomet's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0307 | |||
| Market Risk Adjusted Performance | 0.1948 | |||
| Mean Deviation | 1.13 | |||
| Semi Deviation | 1.47 | |||
| Downside Deviation | 1.58 | |||
| Coefficient Of Variation | 3200.39 | |||
| Standard Deviation | 1.49 | |||
| Variance | 2.22 | |||
| Information Ratio | 0.0226 | |||
| Jensen Alpha | 0.036 | |||
| Total Risk Alpha | 0.0316 | |||
| Sortino Ratio | 0.0213 | |||
| Treynor Ratio | 0.1848 | |||
| Maximum Drawdown | 8.09 | |||
| Value At Risk | (2.26) | |||
| Potential Upside | 2.46 | |||
| Downside Variance | 2.51 | |||
| Semi Variance | 2.16 | |||
| Expected Short fall | (1.14) | |||
| Skewness | (0.50) | |||
| Kurtosis | 1.48 |
| Risk Adjusted Performance | 0.0307 | |||
| Market Risk Adjusted Performance | 0.1948 | |||
| Mean Deviation | 1.13 | |||
| Semi Deviation | 1.47 | |||
| Downside Deviation | 1.58 | |||
| Coefficient Of Variation | 3200.39 | |||
| Standard Deviation | 1.49 | |||
| Variance | 2.22 | |||
| Information Ratio | 0.0226 | |||
| Jensen Alpha | 0.036 | |||
| Total Risk Alpha | 0.0316 | |||
| Sortino Ratio | 0.0213 | |||
| Treynor Ratio | 0.1848 | |||
| Maximum Drawdown | 8.09 | |||
| Value At Risk | (2.26) | |||
| Potential Upside | 2.46 | |||
| Downside Variance | 2.51 | |||
| Semi Variance | 2.16 | |||
| Expected Short fall | (1.14) | |||
| Skewness | (0.50) | |||
| Kurtosis | 1.48 |
Consider Zimmer Biomet's intraday indicators
Zimmer Biomet intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zimmer Biomet stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 34294.95 | |||
| Daily Balance Of Power | (0.29) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 110.83 | |||
| Day Typical Price | 110.68 | |||
| Price Action Indicator | (0.88) | |||
| Period Momentum Indicator | (0.86) | |||
| Relative Strength Index | 60.68 |
Zimmer Biomet Corporate Filings
F3 | 13th of March 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 7th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 25th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 19th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Zimmer Stock media impact
Far too much social signal, news, headlines, and media speculation about Zimmer Biomet that are available to investors today. That information is available publicly through Zimmer media outlets and privately through word of mouth or via Zimmer internal channels. However, regardless of the origin, that massive amount of Zimmer data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Zimmer Biomet news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Zimmer Biomet relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Zimmer Biomet's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Zimmer Biomet alpha.
Zimmer Biomet Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Zimmer Biomet can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Zimmer Biomet Holdings Historical Investor Sentiment
Investor biases related to Zimmer Biomet's public news can be used to forecast risks associated with an investment in Zimmer. The trend in average sentiment can be used to explain how an investor holding Zimmer can time the market purely based on public headlines and social activities around Zimmer Biomet Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Zimmer Biomet's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Zimmer Biomet and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Zimmer Biomet news discussions. The higher the estimate score, the more favorable the investor's outlook on Zimmer Biomet.
Zimmer Biomet Maximum Pain Price Across June 20th 2025 Option Contracts
Zimmer Biomet's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Zimmer Biomet close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Zimmer Biomet's options.
Zimmer Biomet Corporate Directors
| Arthur Higgins | Independent Director | Profile | |
| Michael Michelson | Independent Director | Profile | |
| Christopher Begley | Lead Independent Director | Profile | |
| Betsy Bernard | Independent Director | Profile |
Already Invested in Zimmer Biomet Holdings?
The danger of trading Zimmer Biomet Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zimmer Biomet is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zimmer Biomet. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zimmer Biomet Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.41) | Dividend Share 0.96 | Earnings Share 4.43 | Revenue Per Share | Quarterly Revenue Growth 0.043 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Zimmer Biomet's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.